RAPT Therapeutics
At close: Oct 4
After Hours: 4:02PM EDT
Day Range23.64 - 25.0152 Wk Range9.86 - 40.74Open / Close23.82 / -Float / Outstanding21.9M / 29.7M
Vol / Avg.250.9K / 309.6KMkt Cap727.2MP/E-50d Avg. Price24.53
Div / Yield-Payout Ratio-Total Float21.9MEPS-0.62

RAPT Therapeutics Stock (NASDAQ:RAPT), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1


Highest Price Target1


Lowest Price Target1


Consensus Price Target1


Analyst Rating Summary1


Analyst Firms Making Recommendations1

  • Capital One
  • HC Wainwright & Co.
  • SVB Leerink
  • Cantor Fitzgerald
  • Piper Sandler

1calculated from analyst ratings published within the last 6 months

Analyst Ratings for RAPT Therapeutics

All Ratings (0)

Upgrades (0)

Downgrades (0)

Initiations (0)

Analyst Firm
Price Target Change
Rating Change
Previous / Current Rating
Get Alert

RAPT Therapeutics Questions & Answers

What is the target price for RAPT Therapeutics (RAPT)?

The latest price target for RAPT Therapeutics (NASDAQ: RAPT) was reported by Capital One on September 21, 2022. The analyst firm set a price target for $48.00 expecting RAPT to rise to within 12 months (a possible 95.76% upside). 9 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for RAPT Therapeutics (RAPT)?

The latest analyst rating for RAPT Therapeutics (NASDAQ: RAPT) was provided by Capital One, and RAPT Therapeutics initiated their overweight rating.

When is the next analyst rating going to be posted or updated for RAPT Therapeutics (RAPT)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of RAPT Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for RAPT Therapeutics was filed on September 21, 2022 so you should expect the next rating to be made available sometime around September 21, 2023.

Is the Analyst Rating RAPT Therapeutics (RAPT) correct?

While ratings are subjective and will change, the latest RAPT Therapeutics (RAPT) rating was a initiated with a price target of $0.00 to $48.00. The current price RAPT Therapeutics (RAPT) is trading at is $24.52, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.